Orion Biotech Opportunities Corp. (NASDAQ:ORIAW – Get Rating) saw a significant drop in short interest in January. As of January 31st, there was short interest totalling 3,000 shares, a drop of 18.9% from the January 15th total of 3,700 shares. Based on an average daily volume of 8,500 shares, the days-to-cover ratio is presently 0.4 days.

Orion Biotech Opportunities Price Performance

Shares of ORIAW stock opened at $0.31 on Monday. Orion Biotech Opportunities has a 1-year low of $0.02 and a 1-year high of $0.61.

Institutional Investors Weigh In On Orion Biotech Opportunities

An institutional investor recently bought a new position in Orion Biotech Opportunities stock. Gritstone Asset Management LLC acquired a new stake in shares of Orion Biotech Opportunities Corp. (NASDAQ:ORIAW – Get Rating) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 276,000 shares of the company's stock, valued at approximately $42,000.

See Also

• Get a free copy of the StockNews.com research report on Orion Biotech Opportunities (ORIAW)
• MarketBeat Week in Review – 2/6 – 2/10
• Will Snowflake Have Tough Sledding, Trying To Keep Rally Alive?
• The Bottom Is In For Cloudflare Stock
• 3 Tickers Leading a Meme Stock Revival
• Microsoft-Activision Blizzard Merger: Navigating Risk and Reward

Receive News & Ratings for Orion Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.